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ABSTRACT It has been known for some time that dicyclohexylcarbodiimide (DCCD) inhibits the proton translocation function
of the cytochrome c oxidase complex (CcO) and that there is one major site in subunit Ill which is modified upon reaction with
DCCD (Glu-90 for the bovine enzyme). We have examined the reaction of bovine CcO with N-cyclohexyl-N'-(4-dimethylamino-
a-napthyl)carbodiimide (NCD-4), a fluorescent analog of DCCD. NCD-4 labeling of CcO is strongly inhibited by DCCD implicating
Glu-90 of subunit III as the site of chemical modification by NCD-4. The fluorescence of reconstituted NCD-4-labeled bovine
CcO is strongly quenched by hydrophobic nitroxides, whereas hydrophilic nitroxides and iodide ions have a reduced quenching
ability. It is concluded that the Glu-90 of subunit III resides near the protein-lipid interface of the membrane spanning region
of the enzyme. Different quenching abilities of 5-, 7-, 10-, 12-, and 16-4,4-dimethyl-3-oxazolinyloxy-stearic acids suggest that
the NCD-4 label is located in the membrane bilayer in the region near the middle of the hydrocarbon tail of stearic acid. In light
of these results, it is unlikely that Glu-90 is part of a proton channel that is associated with the proton pumping machinery of
the enzyme but the outcome of this study does not eliminate an allosteric regulatory role for this residue.
INTRODUCTION
The cytochrome c oxidase complex (CcO) is the terminal
electron transport protein in the mitochondria of eukaryotes
and the plasma membrane of some prokaryotes. In mammals,
the enzyme is an integral membrane protein consisting of
12-13 different subunits and an assortment of metals in-
cluding copper, iron, zinc, and magnesium. Although the
enzyme exists as a dimer under physiological conditions, the
functional unit appears to be the monomer. Each monomer
contains four redox active metal centers: two heme A moi-
eties (cytochrome a and cytochrome a3), and two copper ions
(CUA and CUB). It is generally agreed that cytochrome a and
CUA mediate the electron transfer from ferrocytochrome c to
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the binuclear center (cytochrome a3 and CUB) where the re-
duction of dioxygen to water occurs. Subunit I contains the
two heme A's and CUB; CUA resides in subunit II.
CcO exploits the sidedness of the membrane to convert
part of the redox-free energy of dioxygen reduction into a
proton electrochemical gradient across the membrane. It ac-
complishes this feat in two ways. In the scalar reaction, re-
ducing equivalents from ferrocytochrome c and the protons
consumed by the reduction of dioxygen are taken from op-
posite sides of the membrane. In the vectorial reaction, pro-
tons are actively transported against a protonmotive force. It
is well established that CcO pumps up to four protons for
each molecule of dioxygen reduced hence a stoichiometry of
-1 H+/e- (Wikstrom, 1977; Casey et al., 1979a; Sigel and
Carafoli, 1980; van Verseveld et al., 1981; Proteau et al.,
1983). From thermodynamic considerations, proton trans-
location can only result from the last two electron transfers
to the binuclear center (Chan and Li, 1990; Babcock and
Wikstrom, 1992). Wikstrom (1989) has confirmed this ex-
pected result by showing that the last two electrons cause the
pumping of four protons and that the proton translocation
ratio for the last two electrons of the dioxygen reduction
cycle must be 2 H+/e-. The relaxation of the proton gradient
formed by CcO and other proteins in the respiratory chain is
coupled to ATP synthesis by the ATP synthase (for reviews
see Brunori et al. (1987), Prochaska and Fink (1987),
Malmstrom (1990), Saraste (1990), Kadenbach et al. (1991),
Muller and Azzi (1991), and Buse and Steffens (1991)).
In recent years, there has been considerable interest in the
molecular mechanism of proton translocation in CcO and the
redox linkage involved in this process. Redox linkage refers
to the coupling of the downhill electron transfer reaction to
the active transport of protons across the osmotic barrier. In
direct coupling, the ligands of a redox center become pro-
tonated and subsequently deprotonated at some point during
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the oxidation-reduction cycle of the metal. A number of di-
rectly coupled models have been proposed for the mecha-
nism of redox linkage (Babcock and Callahan, 1983; Gelles
et al., 1986; Mitchell, 1987, 1988; Woodruff et al., 1991;
Larsen et al., 1992). Models of indirect coupling also have
been proposed (Wikstrom, 1988; Mitchell et al., 1985). In
indirect coupling, the redox state of the metal centers influ-
ences the conformational state of the proton translocating
elements at some distant location in the protein.
A number of investigators have raised the possibility that
some of the indirectly coupled proton translocating elements
of the proton pump might reside in subunit III (Casey et al.,
1980; Thompson et al., 1985; Prochaska and Reynolds, 1986;
Prochaska and Fink, 1987). It has been known for some time
that reaction of the enzyme with DCCD, which modifies
Glu-90 of subunit III (bovine numbering), or removal of sub-
unit III by a variety of methods results in inhibited proton
translocation (Casey et al., 1979b, 1980; Azzi et al., 1981,
Prochaska et al., 1981; Brunori et al., 1985; Putter et al.,
1985; Sarti et al., 1985; Thelen et al., 1985; Thompson et al.,
1985; Finel and Wikstrom, 1986; Prochaska and Reynolds,
1986; Li et al., 1988; Haltia et al., 1991). There are at least
two possible interpretations of these observations. One in-
terpretation is that part or all of the proton translocating el-
ements of the proton pump are located in subunit III. Al-
ternatively, it has been hypothesized that all the proton
translocating elements of the pump are located in subunits I
and II (Haltia et al., 1991). In this scenario, subunit III would
play a role in modulating the allosteric interactions between
subunits I and II in order to accomplish the redox linkage and
to vary the proton to electron stoichiometry. The percentage
of inhibition of proton translocation by DCCD seems to cor-
relate almost perfectly with the percentage of protein labeled
by DCCD (Casey et al., 1980; Prochaska et al., 1981) sug-
gesting that Glu-90 plays at least some role in the mechanism
of proton pumping in CcO. However, point mutations of the
Paracoccus denitrificans enzyme indicate that Glu-90 is not
required for full proton pumping activity (Haltia et al., 1991).
Although deletion of the subunit III gene in P. denitrificans
results in decreased cytochrome c oxidizing activity (<5% of
wild-type as measured in spheroplasts) (Haltia et al., 1991)
and defective assembly of CcO (Haltia et al., 1989, 1991)
indicating that subunit III plays an important role in the
biogenesis of CcO, identical proton pumping activity is
observed in the subunit III deletion mutant further arguing
against a role for subunit III in proton translocation (Haltia
et al., 1991). We question this result, however, because the
low activity of the mutant enzyme should make turnover
comparable to the rate of protonic leaks, thus predicting a
noticeable decrease in proton pumping efficiency (i.e.,
lower respiratory control). In addition, we find it difficult
to accept that a defectively assembled enzyme complex
should have lower electron transfer activity yet full proton
pumping activity.
There exist no data to exclude a regulatory role for subunit
III, however; such a regulatory role has been postulated by
many investigators (Brunori et al., 1985, 1987; Putter et al.,
1985; Sarti et al., 1985; Wikstrom and Casey, 1985; Finel and
Wikstrom, 1986; Prochaska and Fink, 1987). If so, DCCD
modification of Glu-90 may modify the tertiary folding of
this subunit which in turn may have deleterious effects on its
ability to exert control over the redox linkage. The allosteric
regulation might even involve Glu-90 more directly if this
residue participates in a salt bridge. Such interactions might
lead to a lowering of the proton to electron stoichiometry
with increasing membrane potential. Since proton to electron
ratios are determined by extrapolation to zero membrane po-
tential, it is not surprising that a modulating effect of subunit
III has never been reported. In order to better delineate the
possibility of subunit III as an allosteric effector, it is first
necessary to obtain some idea of the location of Glu-90
within the protein as a whole. This paper describes the use
of a fluorescent probe to try to locate Glu-90 of subunit III
with respect to the membrane bilayer and the surface of the
protein.
A decade ago, Chadwick and Thomas (1983) demon-
strated that N-cyclohexyl-N'-(4-dimethylamino-a-napthyl)-
carbodiimide (NCD-4) can be used as a fluorescent probe for
DCCD binding sites in proteins with their work on the sar-
coplasmic reticulum (Ca21 + Mg2+)-ATPase. NCD-4 is a
useful probe in that the starting material is nonfluorescent,
yet both the protein adduct (an acylurea) and the side product
of the reaction (a urea) are fluorescent. These two potential
products (see scheme in Fig. 1) are readily distinguished by
different fluorescent maxima (Table 1). Pringle and Taber
(1985) have used NCD-4 and a series of spin-labeled stearic
acids to show that the major carbodiimide binding site on the
mitochondrial proton channel of the bovine FoF, ATPase is
fairly deeply buried within the membrane. In this work, Prin-
gle and Taber assumed a 4-6 AO interaction distance for ni-
troxide quenching of fluorophores (Green et al., 1973). More
recent data by Abrams and London (1992) indicate, however,
an interaction distance of 11-15 A for the quenching of fluor-
TABLE 1 Fluorescence emission maxima of NCD-4
derivatives in various solvents at 230C*
Emission wavelength (nm)t
Ethanol/H20
NCD-4-derivative Hexane Ethanol (1:1, v/v)
N-Acetylurea 398 425 (430)11 440
4)= 0.06'
Urea - § 460 (467)11 473
4) = 0.58'
O-Phenylisourea 435 452 465
* Fluoresence properties of NCD-4 (adapted from Chadwick and Thomas
(1983). NCD-4-acylurea is the adduct with the protein (Fig. 1); NCD-4-
acetylurea is the model compound formed by reaction ofNCD-4 with acetic
acid.
t Excitation was at 330 nm.
§ NCD-4 urea proved too insoluble in hexane for spectral measurements.
Values in parentheses represent corrected emission maxima.
' 4) = quantum yield.
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ophores by spin-labeled lipids. In support of the larger in-
teraction, others have shown that in the case of covalent
fluorophore-nitroxide conjugates, the interaction distance
for nitroxide quenching is as large as 12 A (Green et al.,
1990) and significant quenching occurs over a separation
distance of up to 20 A (Matko et al., 1990). Since the cross
section of a transmembrane a-helix including the
sidechains is on the order of 10 A, any appreciable
quenching of the fluorophore in fluorophore labeled pro-
tein complexes by spin-labeled lipids or fatty acids indi-
cates that the fluorescent label is on or near the surface of
the protein at the protein-lipid interface of the membrane
spanning region of the enzyme. The goal of the present
study is to apply the Pringle and Taber methodology to the
Glu-90 question in CcO.
MATERIALS AND METHODS
Materials
Beef heart CcO was isolated by the method of Hartzell and Beinert (1974).
Enzyme concentrations were determined by using the reduced-minus-
oxidized difference spectrum at 605 nm (AE'-Ox = 24 mM-1 cm-'). Enzyme
preparations were stored at -800C in 25 mM, pH 7.8, K-Phos and 0.5 or
0.1% Brij-35 until ready for use. Native CcO had an activity of -390 s-1
in 10 mM, pH 6.0, K-Phos, 100mM KCl and 0.05% dodecyl-f3-D-maltoside
with an initial ferrocytochrome c concentration of 50 ,tM.
Unless otherwise described below, chemicals were reagent grade, were
obtained from commercial suppliers and were used without further purifi-
cation. NCD-4 and 5-, 7-, and 12-DOXYL-stearic acids were obtained from
Molecular Probes; 10-DOXYL-stearic acid and TEMPO were from Aldrich;
and 16-DOXYL-stearic acid was from Molecular Probes or Aldrich. Car-
bonyl cyanide m-chlorophenylhydrozone (CCCP) was obtained from
Calbiochem; cytochrome c (type VI), and 4-amino-TEMPO were
from Sigma; valinomycin was from Sigma or Calbiochem. Lipids from
Sigma were as follows: bovine heart cardiolipin (CL); synthetic dioleoyl
L-a-phosphatidylcholine (PC), -99%; and synthetic dioleoyl L-a-
phosphatidylethanolamine (PE), -99%. Cholic acid (Sigma) was twice
recrystallized from water/ethanol (1:1, v/v) and stored at 4°C and pH 7.6
as a 20% stock solution of the potassium salt. DEAE Bio-gel was from
Bio-Rad; DE-52 beads were from Whatman, and Sephadex G-25 and
G-100 were from Sigma.
Spectroscopic Methods
Optical absorption spectra and kinetic measurements were obtained with an
HP8452 diode array UV/Vis spectrophotometer. EPR spectra were recorded
using a Varian E-line Century Series X-band spectrometer; protein samples
were at liquid nitrogen temperature and spin-labels were at room tempera-
ture. Steady-state fluorescence spectra were recorded on an SLM 4800 spec-
trofluorimeter equipped with a SMC-210 monochromater controller and
SE-480-485 electronics (SLM Instruments) which were interfaced to an
IBM XT computer. Scattering data were obtained at 900 to a Spectra-Physics
series 2000 Argon laser beam (488 nm) using a Malvern System 4700c
sub-micron particle analyser interfaced to a Malvern PC 6300.
NCD-4 Modification of CcO
NCD-4-modified CcO (NCD-4-CcO) was prepared as follows. To a 5 ,uM
solution of CcO in 10 mM pH 7.4 K-Phos, 0.1% Brij-35 was added a
100-fold molar excess of NCD-4 from a 100 mM ethanol stock solution. The
mixture was incubated at 4°C for 18 or 24 h and then centrifuged at 20,000
g for 10 min to remove the precipitated urea. The supernatant was con-
centrated to about 100 ,iM using Centricon-lOOs (Amicon). The concen-
trated NCD-4-labeled protein was then applied to a DEAE or DE-52 column
equilibrated with 10 mM pH 7.4 K-Phos, 0.1% Brij-35 (low salt). After
washing with this buffer (to remove the NCD-4-urea), the salt concentration
was increased to 100 mM KCI (high salt) for elution of the protein. The
protein was concentrated (as above), diluted to remove 90% of the KCI, and
concentrated again, the final concentration being accurately determined us-
ing AE'O°x = 24 mM-' cm-'. For the DCCD inhibition experiments, the
enzyme was first incubated with a 100- or 500-fold molar excess of DCCD
(from a 100 mM ethanol stock solution) for 18 h at 4°C; after the addition
of a 100-fold excess of NCD-4, the incubation was continued for another
18 h. Removal of DCCD- and NCD-4-ureas was accomplished by anion
exchange chromatography as described above.
NCD-4-labeled subunits were determined by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). CcO samples were dis-
sociated using 250mM pH 6.2 Tris-HCl, 8 M urea, 3.3% 2-mercaptoethanol,
5% SDS at room temperature for 1 h and run on a LKB2001 vertical elec-
trophoresis unit using a 7%/0.19% (acrylamide/bisacrylamide) stacking gel,
a 14%/0.37% running gel, and a running buffer of 20mM pH 8.4 Tris-base,
240 mM glycine, and 0.1% SDS. Gels were first photographed under UV
illumination to observe the NCD-4 fluorescence; staining with Coomassie
Blue allowed identification of the subunits.
Reconstitution of CcO
CcO vesicles (COVs) were formed by the cholate dialysis technique (Hinkle
et al., 1972). PC/PE/CL lipid mixtures (2:2:1, w/w) were brought to near
dryness under a stream of nitrogen and residual solvent was removed by
vacuum desiccation overnight. The dried lipids were made to a concentra-
tion of 25 mg/ml in 93 mM pH 7.4 K-Phos, 1.5% K-Cholate, and sonicated
to clarity using a model W-375 tip sonicator from Heat Systems-Ultrasonics,
Inc. After cooling for 10 min, 3.5 ml of the sonicated lipids were mixed with
CcO and 100 mM pH 7.4 K-Phos to a final volume of 5.0 ml and CcO
concentration of 2 tM. The protein-lipid solution was then incubated on ice
for 15 min and thereafter centrifuged at 20,000 g for 30 min at 4°C. The
supernatant was dialyzed (Spectra/Por 4 tubing; 12-14,000 molecular
weight cutoff) for at least 22 h at 40C against 75 volumes of 100 mM pH
7.4 K-Phos with three changes of buffer. After dialysis, the vesicles were
centrifuged at 20,000 g for 40 min at 4°C, and the supernatant was stored
at 4°C until use.
Respiratory control ratios (RCRs) of the COVs were determined as fol-
lows. Cytochrome c stock freshly reduced with sodium dithionite was
passed through a 1.5 X 16 cm Sephadex G-25 column equilibrated with 1
mM pH 7.4 K-Phos to remove the excess dithionite. The activity of the
COVs was monitored by following the cytochrome c absorption at 550 nm
as a function of time after the addition of 4 ,itl vesicles to a 2-ml solution
of 40 ,.uM ferrocytochrome c, 8 ,tM CCCP, 7 ,uM valinomycin, and 1 mM
pH 7.4 K-Phos in a stirred cuvette. The initial slope was determined and
compared with that of an equivalent kinetics run with no ionophores to give
the RCR. Typical RCRs for the COVs were between 2 and 3; respiratory
control was almost completely lost in the case of the NCD-4-CcO vesicles
(NCD-4-COVs). Such low respiratory control was most likely due to leaky
vesicles. Light scattering experiments indicate that the vesicles had an av-
erage diameter of 40 to 70 nm. No evidence for particles in the 4.5-20-nm
range was found thus indicating the absence of CcO in a micellar phase.
While respiratory control was poor for these vesicles, it was found necessary
to utilize purified synthetic lipids to reduce contaminating fluorescence from
impurities found in a more conventional vesicular system. Using semi-
purified phosphatidylcholine, RCRs > 5 have been obtained using the iden-
tical reconstitution procedure.
Fluorescence Quenching
Fluorescence emission spectra of the NCD-4-COVs and COVs were ob-
tained by exciting the sample at 320 nm and scanning from 350 to 550 nm.
All bandwidths were 8 nm. 50-200 ,ul of vesicles were brought to 1 ml with
100 mM pH 7.4 K-Phos and the emission spectra were recorded. Quenchers
were added from a stock solution and emission spectra were recorded about
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30 s after the addition of quencher. Difference spectra were computed from
the fluorescence of NCD-4-COVs and COVs observed under identical con-
ditions to obtain the NCD-4-CcO fluorescence spectra in the absence or
presence of quencher. For comparison of NCD-4 quenching efficiencies,
spectra were integrated from 400-550 nm.
Various quenchers were used to obtain information about the labeled
residue. For example, quenching by membrane impermeant iodide ions and
water-soluble TEMPO nitroxides was used to determine exposure of the
residue to the aqueous solvent. Quenching by the more hydrophobic
n-DOXYL-stearic acids was used to indicate location of the fluorescent label
with respect to the interior of the membrane bilayer. DOXYL-stearic acids
labeled with the nitroxide group at varying locations on the fatty acid chain
were used to attempt to pinpoint the depth at which the NCD-4 labeled
residue was buried within the bilayer. It is assumed that the DOXYL-stearic
acids tend to orient themselves perpendicular to the plane of the bilayer with
their carboxyl groups anchored at the bilayer-aqueous interface. The stearic
acid acting as the most effective quencher is assumed to have the nitroxide
positioned nearest the NCD-4 labeled residue.
Spin-labeled stearic acid stock solutions were made approximately 100
mM in ethanol. First derivative EPR spectroscopy was used to determine
the relative concentrations of spin-labels in these stock solutions as follows.
First derivative EPR spectra were taken of three different aliquots of all stock
solutions. Peak to trough heights of the middle band were assumed to be
proportional to the concentration of spin-label and an average height was
determined for each of the stearic acid stock solutions. The average height
over all spin-labels was assumed to correspond to 100 mM, and this intensity
was used to determine the concentration of each spin-label stock solution.
We note that in ethanol solution, all of the DOXYL nitroxides used should
have similar EPR line widths so the spin concentration can be determined
from the height of the central line. The concentration of the 4-amino-
TEMPO stock solution was determined by comparison of its EPR signal
with that of an accurately made TEMPO stock solution. All spin label so-
lutions were stored at -80°C until use. Potassium iodide solutions were
prepared immediately before use. The NCD-4-acetylurea model compound
was synthesized by reaction of NCD-4 with acetic acid as described by
Chadwick and Thomas (1983).
respective phases; QL and QA denote the amount (e.g., in milligrams) of
quencher in the two phases; and M is the molecular weight of the
quencher. Since the total amount of quencher in an aqueous vesicle solu-
tion is QT = [QILVLM + [Q]AVAM, the overall concentration of
quencher is given by:
QTri VL' (VA\[Q]T V M [Q]L( VT) Q]VT)
(2)[Q] + Q]LVT ) KP)
where it is assumed that the volumes are additive, i.e., VT VA + VL.
This result may be rewritten as:
[Q]T= [Q1L4 + [L(1 - (3)
where n = QJJL is the quencher to lipid ratio, L is the amount of lipid in
solution (e.g., in milligrams); and [L] = L/VT, i.e., the overall lipid con-
centration (e.g., in milligrams/ml).
Equation 3 can be used in conjunction with the fluorescence data to
provide an estimate ofKP for a given quencher through a comparison of the
[QIT values required to achieve a given quenching efficiency at various lipid
concentrations, [L]. It is assumed in this analysis that the measured quench-
ing efficiency (FOIF) provides a direct measure of [Q]L. As [L] increases,
the total amount of quencher ([Q]T) necessary to yield the same observed
fluorescence increases. On the other hand, [Q]L is expected to be the same
for identical quenching efficiencies. Similarly, from the partition equilib-
rium, [QIA is expected to be essentially a constant for a given quenching
efficiency by a given quencher. Plotting [QIT against [L] for a given quench-
ing efficiency according to Eq. 3 therefore should yield a common
y-intercept, namely [Q]A, for this value of [Q]L (n is also essentially a
constant for a given [Q]L). After determining [QIA in this manner and as-
suming that VA/VT 1 (i.e., sufficiently dilute lipid suspensions), one can
estimate [QIL by rearranging the first equality in Eq. 2:
[Q]L - [[Q]-T [Q]QA]
Data Analysis
Fluorescence quenching by spin-labeled stearic acids has previously been
employed to map the location of fluorescent groups in membrane bilayers.
Pringle and Taber (1985) used these spin probes to locate the major car-
bodiimide binding site on the mitochondrial proton channel of the bovine
FoF, ATPase. Chatelier et al. (1984) used DOXYL-stearic acids to deter-
mine the distribution of tryptophan residues in the purple membranes of
Halobacterium halobium. The latter investigators noted that the various
DOXYL-stearic acids used had different effective partition coefficients for
their equilibrium distribution between membrane and aqueous phases. Since
it is the concentration of spin-label in the membrane phase that is responsible
for the observed quenching of a fluorophore within this phase, it is necessary
to determine either the partition coefficient or the concentration of quencher
within the membrane phase for each quencher in order to interpret the
quenching data in a meaningful way. Toward this end, the quenching of
NCD-4-COVs was examined as a function of lipid concentration. These data
allow comparison of the quenching by different nitroxides at the same ef-
fective concentration of quencher within the membrane phase.
The vesicle solution is best treated as a two-phase system. The
partitioning of the quencher between the lipid and aqueous phases is
described by:
K AQL Q]L (1)
AQA [Q]A(1
where A denotes the activity of the quencher in the respective phase, and
these activities can be approximated by the concentration of the quencher
in the appropriate phase. [QIL = QLIVLM and [QIA = QA/VAM are the
concentrations (e.g., in moles/liter) of quencher in the lipid and aqueous
phases, respectively; VL and VA are the volumes (e.g., in milliliters) of the
(4)
The determination of [QIA and [QIL by this method allows estimation of
KP by Eq. 1. Since it is the concentration of quencher in the lipid, [QIL,
not the total quencher concentration, [Q]T, that determines the observed
fluorescence, it is only meaningful to compare the effectiveness of vari-
ous quenchers at the same [QIL. For a given concentration of lipid, [LI,
plotting quenching efficiency against [QIL for the different spin-labels
yields the information necessary to map the approximate location of the
fluorescent probe vis-a-vis the plane of the bilayer. Finally, for a
quencher that is preferentially partitioned into the lipid phase, say KP 2
104, [QIT >> [QIA if VT/VL < 1000 in which case [Q]L may be adequately
approximated by [Q]L (VT/VL)[Q]T.
RESULTS
NCD-4 Labeling of CcO
The reaction of NCD-4 with CcO can potentially yield two
fluorescent products with overlapping fluorescence spectra,
an NCD-4-acylurea and NCD-4-urea (Fig. 1). According to
Chadwick and Thomas (1983), the quantum yield of fluo-
rescence of NCD-4-urea is about 10 times greater than that
of NCD-4-acylurea (adduct with protein-see Table 1) and
therefore interferes with attempts to monitor quenching of
the fluorescence from the labeled protein. This problem is
accentuated by the fact that a 100-fold molar excess of
NCD-4 is required to obtain sufficient labeling of the protein
and this excess results in a great deal of the undesired urea.
Some of this NCD-4-urea is easily removed since it has a low
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FIGURE 1 Schematic representation of the possible reactions following an initial modification of a single carboxyl group in a protein by NCD-4 (Chadwick
and Thomas, 1983; Azzi et al., 1984).
solubility and precipitates out of solution. The remaining
NCD-4-urea seems tightly associated with the protein as evi-
denced by the fact that the residual NCD-4-urea was not
removed upon passing the sample through a 1.5 X 15 cm
G-100 column. Likewise, there was virtually no loss of the
NCD-4-urea upon 16 h dialysis against a 100-fold excess of
detergent-buffer (Fig. 2, a-c).
On the other hand, almost all of the urea can be removed
by applying the protein to a DE-52 or DEAE column and
washing with about 200 ml of buffer (low salt) before elution
(high salt). EPR spectroscopy reveals, however, that a sig-
nificant amount of CUA is converted to a type-IT-like copper
(Li et al., 1988) with this purification procedure (EPR data
not shown). Decreasing the volume of the wash buffer to
about 50 ml limits the modification of CUA; however, the
removal of the NCD-4-urea is incomplete (see Fig. 2, d
and e). Interestingly, this remaining NCD-4-urea is lost
during the formation of vesicles by cholate dialysis. Re-
constitution of NCD-4-CcO without any removal of NCD-
4-urea by anion exchange chromatography also yields
vesicles devoid of the NCD-4-urea impurity. Thus, the an-
ion exchange chromatography step was either omitted or
the NCD-4-CcO was washed with only 50 ml buffer on a
DEAE column before reconstitution for use in the fluores-
cence quenching experiments.
SDS-PAGE indicates that NCD-4 labels predominantly
subunit III of CcO (Fig. 3). A small amount of fluorescence
from subunits I and IV was sometimes observed; this phe-
nomenon depended on preparation of enzyme and was not
investigated further. The fluorescence from subunit III al-
ways appeared much bluer than that from subunits I and IV
which was yellowish; this yellowish fluorescence was simi-
lar in color to the tryptophan fluorescence observed from the
native subunit I. The modification of subunits I and IV by
NCD-4 thus appears minimal.
DCCD inhibition of NCD-4 labeling of CcO
Reaction of CcO with DCCD before incubation with NCD-4
results in reduced NCD-4-acylurea fluorescence per mole of
protein. Using samples treated identically except for the
amount of DCCD added to the solutions, it was determined
that a 100-fold excess ofDCCD inhibited NCD-4 labeling by
about 53%; a 500-fold excess of DCCD inhibited labeling by
about 70%. In order to reduce the interfering NCD-4-urea
fluorescence, these samples were washed on a DE-52 column
with about 200 ml of low salt buffer before elution and the
fluorescence spectra were integrated from 400 to 410 nm.
SDS-PAGE reveals that NCD-4 labeling of subunit III is
inhibited by DCCD (Fig. 3). A comparison of the fluores-
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FIGURE 3 SDS-PAGE of NCD-4-CcO: (left) fluorescence, (right)
Coomassie Blue stain. Lane 1, native CcO; lane 2, CcO treated with a
100-fold molar excess of NCD-4; lane 3, CcO treated with a 100-fold molar
excess of DCCD before reaction with a 100-fold molar excess of NCD-4;
lane 4, CcO treated with a 500-fold molar excess of DCCD before reaction
with a 100-fold molar excess of NCD-4. All samples were depleted of
NCD-4-urea before electrophoresis by washing with - 200 ml low salt
buffer on a DE-52 column before elution as described in Materials and
Methods (i.e., fluorescence emission spectra of samples like that of Fig. 2
e). In each case, there is 168 jig total protein per lane.
FIGURE 2 Fluorescence spectra ofNCD-4-CcO following various levels
of purification. (a) NCD-4-CcO after a 1.5 X 15 cm G-100 column;
(b) NCD-4-CcO after a 1.5 X 15 cm G-100 column and 16-h dialysis;
(c) NCD-4-CcO after two 1.5 X 15 cm G-100 columns and 16-h dialysis;
(d) NCD-4-CcO after a 50-ml wash on a DEAE column; (e) NCD-4-CcO
after a 200-ml wash on a DEAE column. The fluorescence maximum of the
NCD-4-protein adduct occurs at about 405 nm, and the NCD-4-urea has an
emission maximum at about 445 nm. All emission spectra were obtained in
10mM pH 7.4 K-Phos, 0.1% Brij-35 with excitation wavelength of 320 nm.
The small peak at about 360 nm is a Raman band of water.
cence of subunit III when NCD-4 is reacted with native pro-
tein (Fig. 3, lane 2) with the subunit III fluorescence resulting
from incubation of NCD-4 with DCCD-inhibited enzyme
(lanes 3 and 4) indicates that DCCD almost completely in-
hibits NCD-4 labeling of CcO. These DCCD inhibition re-
sults strongly suggest that NCD-4 and DCCD modify the
identical site on CcO; thus, NCD-4 should be effective as a
fluorescence probe of the Glu-90 DCCD binding site.
FLUORESCENCE QUENCHING OF NCD-4-COVS
The NCD-4-CcO fluorescence was investigated over the
range of quencher concentrations where FO/F ranged
from unity to about 2. Fo is the fluorescence in the
absence of quencher and F is the fluorescence at a given
quencher concentration. Quenching is predicted by the
Stern-Volmer equation:
F = (1 + kqT0[Q])(1 + Ka[Q])
F = (1 + K,,[Q])(1 + Ka[Q])
centration of the quencher. Equation 5 predicts that the ob-
served quenching efficiency is second order with respect to
the quencher concentration. Thus, the quenching data were
fitted to a second degree polynomial.
The lipids used for the formation of vesicles were not
completely devoid of fluorescent impurities; however, the
subtraction of a COV spectrum from an NCD-4-COV spec-
trum obtained under identical conditions should correct for
the contribution of these impurities to the emission spectrum
(Fig. 4). The DOXYL-stearic acids employed in this study
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where kq is the bimolecular quenching constant; To is the
fluorescence decay time of the fluorophore in the absence of
the quencher; K, is the dynamic quenching constant; Ka is
the static quenching constant; and [Q] is the effective con-
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FIGURE 4 Typical fluorescence titration curves of (A) NCD-4-COVs
and (B) COVs with 12-DOXYL-stearic acid as the quencher ([Q]T = 0-716
jiM). The lipid concentration was 2.19 mg/ml. (C) depicts the set of dif-
ference spectra (A-B) used to calculate the quenching efficiencies at the
various quencher concentrations.
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contain fluorescence impurities as well, but the simple sub-
traction procedure used should be sufficient also to eliminate
any undesired contribution of these impurities to the emis-
sion spectrum. In the case of titration with 7-DOXYL-stearic
acid at high lipid concentrations, however, subtraction of a
COV spectrum from an NCD-4-COV spectrum obtained un-
der identical conditions apparently did not suffice to isolate
the NCD-4 emission. The fluorescence maximum in the
quenching of NCD-4 fluorescence with 7-DOXYL-stearic
acid at [L] = 3.50 mg/ml (as analyzed by the subtraction
procedure described) was blue-shifted -7 nm and the fluo-
rescence peak became distorted toward the red (data not
shown). Accordingly, the 7-DOXYL-stearic acid quenching
data for [L] = 3.50 mg/ml were not included in the analysis.
A representative plot summarizing the fluorescence
quenching of NCD-4-COVs by the DOXYL-stearic acids is
shown in Fig. 5 A. The data represent quenching by 12-
DOXYL-stearic acid at four different lipid (vesicle) con-
centrations. For each lipid concentration, the data were fitted
to a second degree polynomial. Using these best fit curves,
the DOXYL-stearic acid concentration that yielded a given
FO/F were estimated for each of the four lipid concentrations
studied. The result is the family of curves shown in Fig. 5 B,
where the total quencher concentration required to achieve
a given quenching level is plotted against the four lipid con-
centrations. According to Eq. 3, the y-intercept of each of
these curves (corresponding to various quenching efficien-
cies) is the quencher concentration in the aqueous phase,
[QIA. Using this value for [Q]A and estimating the lipid den-
sity as 1.0 g/cm3, one can calculate the concentration of
quencher in the lipid phase, [QIL, for a given quenching
efficiency according to Eq. 4. Based on these results, one can
estimate Kp, i.e., the ratio of [Q]L to [Q]A (Eq. 1). It turns out
that Kp is on the order of 103-104, which is sufficiently large
that the plots of [Q]T VS. [L] approach straight lines with nIM)
as the slope for a given quenching efficiency (Eq. 3), thus
allowing a direct determination of n.
Finally, FO/F can be replotted against n and the effec-
tiveness of different quenchers can be directly assessed. The
results for the various DOXYL-stearic acids utilized in this
study are consolidated in Fig. 6 to facilitate this comparison.
Summarized here are the results from two completely inde-
pendent sets of experiments (different starting protein, dif-
ferent vesicle sizes, etc.). These data suggest that 7- and
10-DOXYL-stearic acids are the most effective quenchers
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FIGURE 5 (A) Quenching efficiency against 12-DOXYL-stearic acid
concentration for four different lipid concentrations, [L]: 0.875 (O), 1.31
(U), 2.19 (0), and 3.50 (0) mg/ml. (B) The data were replotted according
to Eq. 3 after estimating the total 12-DOXYL-stearic acid concentration
required to achieve a given quenching efficiency (FO/F) for the different
lipid concentrations: FOIF = 1.25 (L), 1.50 (U), 1.75 (0), 2.00 (0).
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FIGURE 6 Quenching efficiency plotted against n, the quencher/lipid
weight ratio, for several different DOXYL-stearic acids. The two plots A
and B summarize data obtained from two different sets of experiments:
5-DOXYL (E[), 7-DOXYL (U), 10-DOXYL (A), 12-DOXYL (0), 16-
DOXYL (0).
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and 16-DOXYL-stearic acid is the least effective in quench-
ing the fluorescence of NCD-4-CcO. The inescapable con-
clusion that one can draw from these data is that the NCD-4
probe is located close to the lipid exposed region of CcO in
the modified enzyme.
Since the partition coefficient for the DOXYL-stearic ac-
ids is large (103-104), the bulk of the quencher molecules
reside in the lipid phase and [Q]A << [Q]T. Accordingly, a
comparison of the various DOXYL quenchers may be made
by plotting FO/F vs. [Q]L as in Fig. 7, with [Q]L estimated
by VT/VL [Q]T. Note the similarity between the plots ofFO/F
vs. n (Fig. 6) and FO/F vs. [Q]L (Fig. 7). In each case, the
identical conclusion is reached regarding the location of the
NCD-4 probe vis-'a-vis the bilayer membrane and the surface
of the protein, namely, that the NCD-4 label is located near
carbon positions 7-10 of stearic acid.
As controls, the quenching of NCD-4-COVs by KI as well
as by two water soluble nitroxides, TEMPO and 4-amino-
TEMPO, was also studied. Results from these experiments
are summarized in Fig. 8. As expected, the most hydrophobic
of the soluble nitroxides (TEMPO) proved to be the most
effective quencher and KI was the least effective in quench-
ing of the NCD-4 fluorescence. It may seem somewhat sur-
prising that KI is a more effective quencher of NCD-4-
acetylurea in dodecyl-p3-D-maltoside micelles rather than in
free solution (20% ethanol solution) for one expects the hy-
drophobic model compound to partition preferentially into
the micelle (Fig. 8 B). One should be reminded, however,
that the sugar moieties of the detergent molecules have a high
affinity for iodide ions and hence act to increase the local
concentration of the quencher ion. In any case, the KI
quenching of NCD-4-acetylurea in dodecyl-,B-D-maltoside
micelles clearly establishes iodide as an effective quencher
for the fluorophore in question. Upon comparison of [Q]TS
necessary to yield a given quenching efficiency, it is clear
that the DOXYL-stearic acids were more effective in
quenching the NCD-4-CcO fluorescence than the TEMPO
nitroxides by about one order of magnitude. Note the dif-
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FIGURE 7 Quenching efficiency plotted against [QIL for the different
DOXYL-stearic acids studied. The lipid concentration was 1.31 mg/ml. The
legend is the same as in Fig. 6.
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FIGURE 8 (A) Quenching of NCD-4-CcO by TEMPO and 4-amino-
TEMPO. The lipid concentration was 1.31 mg/ml. (B) Comparison of the
quenching of NCD-4-CcO and the model compound NCD-4-acetylurea by
potassium iodide: (0) NCD-4-CcO ([L] = 1.31 mg/ml), (C1) NCD-4-
acetylurea in ethanol/100 mM pH 7.4 Na-Phos (1:4, v/v), (U) NCD-4-
acetylurea in 100 mM pH 7.4 Na-Phos, 0.1% dodecyl-f3-D-maltoside.
ferent abscissa scales for the DOXYL (Fig. 5 A), TEMPO
(Fig. 8 A) and the heavy atom quenchers (Fig. 8 B). These
results are consistent with the conclusions derived from the
DOXYL-stearic acid quenching experiments that the NCD-4
probe in the modified CcO resides at or close to the surface
of the protein in the hydrophobic region exposed to the mem-
brane bilayer.
DISCUSSION
Reaction of NCD-4 with CcO
N-(2,2,6,6-Tetramethylpiperidyl-1-oxyl)-N' -cyclohexyl-
carbodiimide (NCCD), a spin-label analog of DCCD, ap-
pears to modify CcO at the DCCD site (Casey et al.,
1981a,b), suggesting that NCD-4 would label also at this site.
The inhibition of NCD-4 labeling of the enzyme by DCCD
confirms this expectation.
In the course of these experiments, it was found that fairly
harsh conditions (anion exchange chromatography which
tends to modify CcO) were necessary to completely isolate
the fluorescently labeled protein from the NCD-4-urea si-
deproduct. According to Chadwick and Thomas (1983), the
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fluorescence maximum of NCD-4-urea can be an effective
indicator of the solvent dielectric in the immediate vicinity
of this side product. These investigators have reported that
NCD-4-urea has a fluorescence maximum at about 460 nm
in pure ethanol and at about 473 nm in 50% ethanol (Table
1). The Amax of 445 nm observed for the fluorescence emis-
sion of the bound NCD-4-urea (Fig. 2 d) indicates that the
bound NCD-4-urea must be located in a fairly hydrophobic
environment (E < 10).
Glu-90 Resides in a Hydrophobic Environment
Previous work by Casey and co-workers (1981a,b) on
NCCD-labeled CcO indicates that the DCCD binding site is
fairly apolar. The present study provides two lines of evi-
dence in support of this conclusion. First, the Amax of the
fluorescence emission by NCD-4-CcO is consistent with the
idea that the NCD-4 probe is located in a hydrophobic en-
vironment. Second, the apolar location of the NCD-4 probe
is confirmed by the effective quenching of the NCD-4 fluo-
rescence by DOXYL-stearic acids that partition preferen-
tially into the bilayer membrane.
The fluorescence spectrum ofNCD-4-CcO reveals that the
DCCD-binding site is not exposed to the aqueous solvent. In
this study, the fluorescence maximum of NCD-4-CcO never
exceeded 425 nm. Chadwick and Thomas (1983) have re-
ported a fluorescence maximum for N-acetylurea of about
398 nm in hexane, 425 nm in ethanol, and 440 nm in 50%
ethanol (Table 1). In our hands, the NCD-4-acetylurea model
compound has a fluorescence maximum of about 420 nm in
dodecyl-3-D-maltoside micelles and 440 nm in 20% ethanol
(data not shown). It thus appears that the NCD-4 probe is
located in a fairly hydrophobic environment. Interestingly,
the detergent (Brij-35) solubilized NCD-4-CcO exhibits a
fluorescence maximum at about 405 nm (Fig. 2), though the
maximum is around 425 nm (Fig. 4) in the reconstituted
protein. This difference in Amax of the emission most likely
reflects the different environments surrounding the NCD-4
probe in the detergent solubilized and reconstituted proteins.
It is clear that the different effectiveness of the DOXYL-
stearic acids, the TEMPO derivatives and KI in quenching
the fluorescence of NCD-4-COVs indicates that the NCD-4
probe is located in a hydrophobic environment. Our aim in
using the various DOXYL-stearic acids was to pinpoint the
depth at which NCD-4 is embedded within the membrane
bilayer. While none of the DOXYL derivatives used is
clearly the most effective quencher, the data suggests that the
NCD-4 probe resides at a membrane depth near the middle
of the hydrocarbon chain of stearic acid in the region near
carbon positions 7-10 (Figs. 6 and 7). Our data indicate that
16-DOXYL-stearic acid was the least effective DOXYL
quencher. If we assume that the probe is not located in the
central region of the membrane (11-16-carbon region of
stearic acid) as our data suggest, then the distance between
quencher planes of the two leaflets is >10-12 A. This dis-
tance is basically the critical interaction distance indicating
that quenching from the opposite leaflet is most likely in-
significant. A calculation using the "parallax" method
(Abrams and London, 1992) validates these general conclu-
sions. The effectiveness of a given nitroxide as a quencher
depends upon the distance of closest approach to the NCD-4
fluorophore, and this distance is constrained by its position
on the hydrocarbon chain as the fatty acid anchors itself in
the membrane. It is important to point out that the DOXYL-
stearic acid quenching data allow determination of the po-
sition of the NCD-4 fluorophore, not that of Glu-90, within
the membrane bilayer. The center of the fluorescent naph-
thalene moiety of the NCD-4 probe can be as far as - 5 A
away from the carboxyl carbon of Glu-90. In any case, it is
clear that the NCD-4 label, and by extension Glu-90, is lo-
cated in a domain of subunit III that is embedded within the
lipid milieu. The high concentrations of water soluble
quenchers required to quench the NCD-4-CcO fluorescence
is consistent with this picture. The effectiveness of 4-amino-
TEMPO and TEMPO as quenchers (as manifested by the
[Q]T necessary to achieve a given quenching efficiency) is
less by an order of magnitude when compared to the
DOXYL-stearic acids (compare Figs. 5 A and 8 A). If one
assumes that both the TEMPO and DOXYL nitroxides have
similar intrinsic quenching efficiencies and they affect the
observed fluorescence only when they are present in the lipid
phase, the partition coefficient for the TEMPO nitroxides is
on the order of 101_102 (compare Figs. 7 and 8A) compared
to 103-104 for the DOXYL-stearic acids. Even higher con-
centrations of potassium iodide (another two orders of mag-
nitude) are required to achieve comparable quenching as the
water-soluble TEMPO nitroxides.
Possible Role of Glu-90 in CcO Function
Since Glu-90 is strictly conserved in all known sequences,
it is likely that this residue plays an important role in the
function of CcO. Although Glu-90 may not be part of a pro-
ton channel as previously suggested, this residue, as well as
subunit III, may still have some functional role in the proton
pumping function of CcO. At the very least, subunit III can
play a structural role (also suggested by Haltia et al. (1991))
as it has been known for some time that the ligand structure
of CUA in subunit II becomes unstable upon subunit III-
depletion (Li et al., 1988). Moreover, subunit III could serve
as an allosteric effector and modulate the allosteric interac-
tions between subunits I and II that are expected to be obliga-
tory for redox linkage. One scenario is that these allosteric
interactions can be tuned by subunit III to allow modulation
of the proton to electron stoichiometry as a function ofmem-
brane potential. Since two protons are pumped per electron
for the last two electrons of a turnover cycle (Wikstrom,
1989), it is possible that one proton is pumped in a directly
coupled fashion and the second proton is linked to (a) redox
center(s) in an indirect fashion (Chan and Li, 1990). Under
sufficiently high membrane potential, it is conceivable that
the indirect mechanism may become disengaged, and it may
be that subunit III is involved here. If there is any truth to this
scenario, it predicts that substitution of Glu-90 by site-
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directed mutagenesis will merely disrupt the ability of the
proton pump to respond to varying energized states of the
mitochondrion. This is a testable hypothesis. To date, how-
ever, H+/e- ratios in proton pumping experiments involving
native and mutant CcO have been determined only by ex-
trapolation to zero membrane potential. To explore the
modulating effect of subunit III, specifically Glu-90, it is
necessary to compare the response of native and mutant CcO
as a function of transmembrane potentials in detail. Finally,
since exposure of Glu-90, a strictly conserved charged resi-
due, to the interior of the membrane bilayer is extremely
unfavorable energetically, it is possible that Glu-90 salt-
bridges with one of the two strictly conserved histidines of
subunit III (His-204 and His-243-bovine numbering) that
are predicted to be part oftransmembrane helices on the basis
of hydropathy plots (Fig. 9).
CONCLUSIONS
1. In light of these fluorescence results, we conclude that the
Glu-90 of subunit III resides near the protein-lipid interface
of the membrane spanning region of the enzyme. A proton
channel through the protein is expected to be inaccessible
from the lipid bilayer and confined, allowing passage of mol-
ecules no larger than H30+. Since the interaction distance for
fluorescence quenching by nitroxides is 11-15 A (Abrams
and London, 1992) and the diameter of a transmembrane
helix is .10 A, it is evident from our results that Glu-90
could be on the interior side of a helix in contact with the lipid
bilayer. This situation would allow Glu-90 to be part of a
proton channel through the protein. However, the reaction of
diimides with Glu-90 would likely disrupt the helix-helix
packing and/or reorient the membrane helices to accommo-
date the bulky label. As there is no experimental evidence for
such a major conformational change upon reaction of the
FIGURE 9 Subunit III sequence of bovine HAA
heart CcO. Shaded residues are those strictly F(I
conserved in 36 cytochrome c oxidase subunit
III sequences (Mather et al., 1993). Putative
transmembrane helices based on hydropho-
bicity (hydrophobicity scale of Engelman L
et al. (1986)) are boxed and the cytosolic and (
matrix sides of the membrane are denoted T
"outside" and "inside," respectively (Mather L Q
et al., 1993). The glutamate residue labeled by R--- w
DCCD and NCD-4 and the two strictly con- D
served histidines that could salt-bridge to p v
Glu-90 are labeled. N I
enzyme with DCCD or NCD-4, we prefer a scenario in which
Glu-90 is exposed to the lipid milieu. If this is the case,
Glu-90 is unlikely to be an element of a proton channel as-
sociated with the proton pumping machinery of the enzyme.
Our results agree with the mutagenesis results of Haltia et al.
(1989) which showed that that Glu-90 is not an element of
a proton channel and with previous work that established that
the DCCD binding site resides in a hydrophobic environment
(Casey et al., 1981a,b). However, this is the first study that
attempts to three-dimensionally locate Glu-90 and we ex-
perimentally validate the placement of Glu-90 in a trans-
membrane helix based on hydropathy plots (Fig. 9). In ad-
dition, we show that Glu-90 is a surface or near-surface
residue exposed to the lipid environment.
2. This is the first study utilizing the fluorescence probe
NCD-4 to examine the DCCD binding site. It was found that
the emission maxima for the detergent-solubilized and re-
constituted NCD-4 labeled protein were different likely in-
dicating different conformations in a micellar and bilayer
environment. Such conformational modifications may be a
consequence of the important role of phospholipids (espe-
cially cardiolipin) in enzyme turnover (Abramovitch et al.,
1990; Robinson et al., 1990).
3. This is the first report providing evidence for a binding
site for a sideproduct of incubation with carbodiimides (in
this case, NCD-4-urea). It is likely that NCD-4-urea binds
nonspecifically to hydrophobic regions of the enzyme. On
the other hand, NCD-4-urea may bind more specifically sug-
gesting a binding site for dicyclohexylurea which may be
responsible, in part, for the reduced proton pumping ability
of the DCCD treated enzyme. Additional support for this
hypothesis comes from the work of Lehninger and co-
workers (1985). These investigators found that the proton
pumping activity of CcO is partially inhibited immediately
after addition of DCCD presumably before the enzyme is
I II m IV v
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modified by DCCD at Glu-90 of subunit III suggesting that
hydrophobic binding of DCCD may inhibit proton pumping
activity.
4. Finally, a novel methodology for interpreting fluores-
cence quenching results using stearic acid nitroxides is
presented. In contrast to previous studies, the resolution of
the technique appears poor. This is not due to any theoreti-
cal difficulties, but rather arises from the large size of the
fluorophore utilized and the large conformational space
sampled by the fluorophore. Our conclusion that the
NCD-4 probe resides near the protein-lipid interface of the
membrane spanning region of the enzyme is firm, how-
ever, based on the quenching abilities of water soluble
TEMPO derivatives and KI.
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